Anne L Wyllie1, Joshua L Warren2, Gili Regev-Yochay3,4,5, Noga Givon-Lavi6, Ron Dagan6, Daniel M Weinberger1. 1. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA. 2. Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. 3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Gertner Institute, Tel-Hashomer, Israel. 5. Infectious Diseases Unit, Sheba Medical Center, Tel-Hashomer, Israel. 6. Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Abstract
BACKGROUND: The importance of specific serotypes causing invasive pneumococcal disease (IPD) differs by age. Data on pneumococcal carriage in different age groups, along with data on serotype-specific invasiveness, could help explain these age-related patterns and their implications for vaccination. METHODS: Using pneumococcal carriage and disease data from Israel, we evaluated the association between serotype-specific IPD in adults and serotype-specific carriage prevalence among children in different age categories, while adjusting for serotype-specific invasiveness. We estimated carriage prevalence using different age groupings that were selected a priori. The Deviance Information Criterion was used to determine which age groupings of carriage data best fit the adult IPD data. Serotype-specific disease patterns were further evaluated by stratifying IPD data by comorbidity status. RESULTS: The relative frequency of serotypes causing IPD differed between adults and children, and also differed between older and younger adults and between adults with and without comorbidities. Serotypes overrepresented as causes of IPD in adults were more commonly carried in older children compared with younger children. In line with this, the serotype-specific frequency of carriage in older children, rather than infants, best correlated with serotype-specific IPD in adults. CONCLUSIONS: These analyses demonstrate that the serotype patterns in carriage in older children, rather than infants, are best correlated with disease patterns in adults. This might suggest these older children are more influential for disease patterns in adults. These insights could help in optimizing vaccination strategies to reduce disease burden across all ages.
BACKGROUND: The importance of specific serotypes causing invasive pneumococcal disease (IPD) differs by age. Data on pneumococcal carriage in different age groups, along with data on serotype-specific invasiveness, could help explain these age-related patterns and their implications for vaccination. METHODS: Using pneumococcal carriage and disease data from Israel, we evaluated the association between serotype-specific IPD in adults and serotype-specific carriage prevalence among children in different age categories, while adjusting for serotype-specific invasiveness. We estimated carriage prevalence using different age groupings that were selected a priori. The Deviance Information Criterion was used to determine which age groupings of carriage data best fit the adult IPD data. Serotype-specific disease patterns were further evaluated by stratifying IPD data by comorbidity status. RESULTS: The relative frequency of serotypes causing IPD differed between adults and children, and also differed between older and younger adults and between adults with and without comorbidities. Serotypes overrepresented as causes of IPD in adults were more commonly carried in older children compared with younger children. In line with this, the serotype-specific frequency of carriage in older children, rather than infants, best correlated with serotype-specific IPD in adults. CONCLUSIONS: These analyses demonstrate that the serotype patterns in carriage in older children, rather than infants, are best correlated with disease patterns in adults. This might suggest these older children are more influential for disease patterns in adults. These insights could help in optimizing vaccination strategies to reduce disease burden across all ages.
Authors: Angela B Brueggemann; Timothy E A Peto; Derrick W Crook; Jay C Butler; Karl G Kristinsson; Brian G Spratt Journal: J Infect Dis Date: 2004-08-25 Impact factor: 5.226
Authors: Jennifer R Scott; Eugene V Millar; Marc Lipsitch; Lawrence H Moulton; Robert Weatherholtz; Mindy J Perilla; Delois M Jackson; Bernard Beall; Mariddie J Craig; Raymond Reid; Mathuram Santosham; Katherine L O'Brien Journal: J Infect Dis Date: 2011-11-29 Impact factor: 5.226
Authors: Gertjan H J Wagenvoort; Elisabeth A M Sanders; Bart J Vlaminckx; Karin E Elberse; Hester E de Melker; Arie van der Ende; Mirjam J Knol Journal: Vaccine Date: 2016-01-08 Impact factor: 3.641
Authors: Joseph A Lewnard; Amit Huppert; Noga Givon-Lavi; Melinda M Pettigrew; Gili Regev-Yochay; Ron Dagan; Daniel M Weinberger Journal: J Infect Dis Date: 2016-08-17 Impact factor: 5.226
Authors: Anna M M van Deursen; Suzan P van Mens; Elisabeth A M Sanders; Bart J M Vlaminckx; Hester E de Melker; Leo M Schouls; Sabine C de Greeff; Arie van der Ende Journal: Emerg Infect Dis Date: 2012-11 Impact factor: 6.883
Authors: Willem R Miellet; Janieke van Veldhuizen; David Litt; Rob Mariman; Alienke J Wijmenga-Monsuur; Paul Badoux; Tessa Nieuwenhuijsen; Rebecca Thombre; Sanaa Mayet; Seyi Eletu; Carmen Sheppard; Marianne Alice van Houten; Nynke Y Rots; Elizabeth Miller; Norman K Fry; Elisabeth A M Sanders; Krzysztof Trzciński Journal: Front Microbiol Date: 2022-04-18 Impact factor: 6.064
Authors: Philip H C Kremer; Bart Ferwerda; Hester J Bootsma; Nienke Y Rots; Alienke J Wijmenga-Monsuur; Elisabeth A M Sanders; Krzysztof Trzciński; Anne L Wyllie; Paul Turner; Arie van der Ende; Matthijs C Brouwer; Stephen D Bentley; Diederik van de Beek; John A Lees Journal: Elife Date: 2022-07-26 Impact factor: 8.713